Filing metadata

Accession number
0001209191-21-021487
Form type
Form 4
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Mar 17, 2021
Reporting period
Mar 04, 2021
Description
Insider transaction

Explore SEC Filings Hub